Michael Girardi

13PUBLICATIONS
43CO-AUTHORS
Epigenetics (incl. genome methylation and epigenomics)Haematological tumoursAllergyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Sep 23, 2026
UV signature mutation hyperhotspots as genomic dosimeters.

|Mar 28, 2026
How We Evaluate and Treat Leukemic Presentations of Mature T-Cell Lymphomas.

Arjun Ravishankar, Vinisha Somaya, Haris Qureshi

|Sep 17, 2025
Sclerotic GVHD and scleroderma share dysregulated gene expression that is ameliorated by EREG therapeutic antibody.

Nathan M Newton, Kriti Agrawal, Anahi V Odell

|Sep 14, 2024
Clinical and Histologic Variants of CD8+ Cutaneous T-Cell Lymphomas.

Madisen A Swallow, Goran Micevic, Amanda Zhou

|Jun 09, 2024
Chart review study of real-world clinical outcomes in patients with cutaneous T-cell lymphoma treated with extracorporeal photopheresis in the US in 2017-2019.

Michael Girardi, Kacie Carlson, Xingyue Huang

|Jan 15, 2024
Generation and optimization of off-the-shelf immunotherapeutics targeting TCR-Vβ2+ T cell malignancy.

Jingjing Ren, Xiaofeng Liao, Julia M Lewis

Pageof 3

Frequent Collaborators

2 joint publications

Shayan Cheraghlou

2 joint publications

Fatima N Mirza

2 joint publications

Sara Yumeen

2 joint publications

Julia M Lewis